{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:46Z","timestamp":1792787866847,"version":"4.5.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Royal Institute of Technology","id":[{"id":"https:\/\/ror.org\/026vcq606","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epigenetic modifications play a crucial role in cancer, influencing cellular physiology, extracellular matrix (ECM) remodeling, and immune responses. With growing emphasis on chromatin remodeling and the epigenetic regulation of immunity, these regulatory pathways and related players have become focal points of oncological investigations. Epigenetic manipulation of immune system components has emerged as a promising strategy in cancer treatment. Several FDA-approved \u201cepi-drugs\u201d target the epigenome to modulate immune responses and offer new opportunities across different cancers. DNA repair pathways contribute significantly to the avoidance of cancer initiation and also contribute to cellular resistance in cancer treatment. Chromatin remodelers such as INO80, Fun30, and RAD54 play essential roles in DNA damage response (DDR) through homologous recombination and non-homologous end-joining pathways, and their dysregulation leads to genome instability and tumor progression. Chromatin remodeling complexes, including SWI\/SNF and CHD families, are frequently altered across various cancer types, further highlighting their role in cancer pathophysiology. Targeting these chromatin modifiers and associated DNA repair mechanisms may provide novel therapeutic options. In addition, combining epigenetic modulators with immunotherapies has shown promise in enhancing responses to immune checkpoint blockade. Epigenetic drugs such as histone deacetylase (HDAC) inhibitors and DNA methylation inhibitors are being explored for their synergistic effects with immunotherapy. While the interplay between chromatin remodeling, DNA repair, and immune responses provides a strong framework for developing targeted oncological strategies, further research is required to better understand these interactions and optimize their clinical application.<\/jats:p>","DOI":"10.1186\/s10020-026-01557-7","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:50:38Z","timestamp":1784163038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of chromatin remodeling and immunopharmacology in cancer therapy"],"prefix":"10.1186","volume":"32","author":[{"given":"Syeda Kiran","family":"Riaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehwish","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farwa","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saboor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafiul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1877-4154","authenticated-orcid":false,"given":"Vaibhav","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"1557_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.molcel.2004.05.016","volume":"14","author":"MW Adkins","year":"2004","unstructured":"Adkins MW, Howar SR, Tyler JK. Chromatin disassembly mediated by the histone chaperone Asf1 is essential for transcriptional activation of the yeast PHO5 and PHO8 genes. Mol Cell. 2004;14:657\u201366.","journal-title":"Mol Cell"},{"key":"1557_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0520-1","volume":"11","author":"T Altmann","year":"2016","unstructured":"Altmann T, Gennery AR. DNA ligase IV syndrome; a review. Orphanet J Rare Dis. 2016;11:137.","journal-title":"Orphanet J Rare Dis"},{"key":"1557_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10577-023-09737-5","volume":"31","author":"JR Andrade","year":"2023","unstructured":"Andrade JR, Gallagher AD, Maharaj J, McClelland SE. Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies. Chromosome Res. 2023;31:28.","journal-title":"Chromosome Res"},{"key":"1557_CR4","doi-asserted-by":"crossref","unstructured":"Ayll\u00f3n V, Rebollo A. Ras-induced cellular events. Mol Membr Biol. 2000;17:65\u201373.","DOI":"10.1080\/09687680050117093"},{"key":"1557_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2006.11.052","volume":"128","author":"A Bagchi","year":"2007","unstructured":"Bagchi A, Papazoglu C, Wu Y, et al. CHD5 is a tumor suppressor at human 1p36. Cell. 2007;128:459\u201375.","journal-title":"Cell"},{"key":"1557_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003663","volume":"10","author":"X Bai","year":"2022","unstructured":"Bai X, Wong CC, Pan Y, et al. Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells. J Immunother Cancer. 2022;10:e003663.","journal-title":"J Immunother Cancer"},{"key":"1557_CR7","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-12-3049","volume":"19","author":"S Balasubramaniam","year":"2013","unstructured":"Balasubramaniam S, Comstock CES, Ertel A, et al. Aberrant BAF57 signaling facilitates prometastatic phenotypes. Clin Cancer Res. 2013;19:2657\u201367.","journal-title":"Clin Cancer Res"},{"key":"1557_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2217\/epi.11.14","volume":"3","author":"Y Bao","year":"2011","unstructured":"Bao Y. Chromatin response to DNA double-strand break damage. Epigenomics. 2011;3:307\u201321.","journal-title":"Epigenomics"},{"key":"1557_CR9","doi-asserted-by":"publisher","first-page":"1034092022","DOI":"10.1016\/j.dnarep.2022.103409","volume":"120","author":"EM Barros","year":"2022","unstructured":"Barros EM, McIntosh SA, Savage KI. The DNA damage induced immune response: Implications for cancer therapy. DNA Repair (Amst). 2022;120:1034092022.","journal-title":"DNA Repair (Amst)"},{"key":"1557_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, Karami J, Zarei Z, et al. Breast cancer: biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535.","journal-title":"Int Immunopharmacol"},{"key":"1557_CR11","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/cdd.2015.173","volume":"23","author":"C Bassi","year":"2016","unstructured":"Bassi C, Li Y-T, Khu K, et al. The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair. Cell Death Differ. 2016;23:1198\u2013208.","journal-title":"Cell Death Differ"},{"key":"1557_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrm.2016.147","volume":"18","author":"M Beck","year":"2017","unstructured":"Beck M, Hurt E. The nuclear pore complex: understanding its function through structural insight. Nat Rev Mol Cell Biol. 2017;18:73\u201389.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1557_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc3007","volume":"11","author":"AC Begg","year":"2011","unstructured":"Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11:239\u201353.","journal-title":"Nat Rev Cancer"},{"key":"1557_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101524","volume":"11","author":"R Begolli","year":"2019","unstructured":"Begolli R, Sideris N, Giakountis A. LncRNAs as chromatin regulators in cancer: from molecular function to clinical potential. Cancers (Basel). 2019;11:1524.","journal-title":"Cancers (Basel)"},{"key":"1557_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","volume":"21","author":"U Ben-David","year":"2020","unstructured":"Ben-David U, Amon A. Context is everything: aneuploidy in cancer. Nat Rev Genet. 2020;21:44\u201362.","journal-title":"Nat Rev Genet"},{"key":"1557_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.bjc.6605201","volume":"101","author":"C Beskow","year":"2009","unstructured":"Beskow C, Skikuniene J, Holgersson \u00c5, Nilsson B, Lewensohn R, Kanter L, et al. Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. Br J Cancer. 2009;101:816\u201321.","journal-title":"Br J Cancer"},{"key":"1557_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cub.2006.01.051","volume":"16","author":"A Brandt","year":"2006","unstructured":"Brandt A, Papagiannouli F, Wagner N, et al. Developmental control of nuclear size and shape by kugelkern and kurzkern. Curr Biol. 2006;16:543\u201352.","journal-title":"Curr Biol"},{"key":"1557_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009657","volume":"5","author":"Y Buganim","year":"2010","unstructured":"Buganim Y, Goldstein I, Lipson D, et al. A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype. PLoS ONE. 2010;5:e9657.","journal-title":"PLoS ONE"},{"key":"1557_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ijc.28705","volume":"135","author":"T Cajuso","year":"2014","unstructured":"Cajuso T, H\u00e4nninen UA, Kondelin J, et al. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer. Int J Cancer. 2014;135:611\u201323.","journal-title":"Int J Cancer"},{"key":"1557_CR20","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1101\/gad.1273105","volume":"19","author":"B Chai","year":"2005","unstructured":"Chai B, Huang J, Cairns BR, Laurent BC. Distinct roles for the RSC and Swi\/Snf ATP-dependent chromatin remodelers in DNA double-strand break repair. Genes Dev. 2005;19:1656\u201361.","journal-title":"Genes Dev"},{"key":"1557_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-387665-2.00009-2","volume":"110","author":"AL Chambers","year":"2012","unstructured":"Chambers AL, Downs JA. The RSC and INO80 chromatin-remodeling complexes in DNA double-strand break repair. Prog Mol Biol Transl Sci. 2012;110:229\u201361.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1557_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev.immunol.19.1.565","volume":"19","author":"CA Chambers","year":"2001","unstructured":"Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol. 2001;19:565\u201394.","journal-title":"Annu Rev Immunol"},{"key":"1557_CR23","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nsmb.2105","volume":"18","author":"X Chen","year":"2011","unstructured":"Chen X, Niu H, Chung W-H, et al. Cell cycle regulation of DNA double-strand break end resection by Cdk1-dependent Dna2 phosphorylation. Nat Struct Mol Biol. 2011;18:1015\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"1557_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature11355","volume":"489","author":"X Chen","year":"2012","unstructured":"Chen X, Cui D, Papusha A, et al. The Fun30 nucleosome remodeller promotes resection of DNA double-strand break ends. Nature. 2012;489:576\u201380.","journal-title":"Nature"},{"key":"1557_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108866","volume":"109","author":"J Chen","year":"2022","unstructured":"Chen J, Chen X, Li T, Wang L, Lin G. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response. Int Immunopharmacol. 2022;109:108866.","journal-title":"Int Immunopharmacol"},{"key":"1557_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051031","volume":"13","author":"A Ciner","year":"2025","unstructured":"Ciner A, Hosein PJ, Jiang Y, Rassool F. The interplay between DNA repair and the immune microenvironment in pancreatic cancer. Biomedicines. 2025;13:1031.","journal-title":"Biomedicines"},{"key":"1557_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","volume":"78","author":"CR Clapier","year":"2009","unstructured":"Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem. 2009;78:273\u2013304.","journal-title":"Annu Rev Biochem"},{"key":"1557_CR28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1158\/2159-8290.CD-21-0248","volume":"12","author":"CP Concepcion","year":"2022","unstructured":"Concepcion CP, Ma S, LaFave LM, et al. Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung. Cancer Discov. 2022;12:562\u201385.","journal-title":"Cancer Discov"},{"key":"1557_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1973783","volume":"10","author":"MP Correia","year":"2021","unstructured":"Correia MP, Stojanovic A, Wels WS, Cerwenka A. Innate-like NKp30 + CD8 + T cells armed with TCR\/CAR target tumor heterogeneity. Oncoimmunology. 2021;10:1973783.","journal-title":"Oncoimmunology"},{"key":"1557_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nature11353","volume":"489","author":"T Costelloe","year":"2012","unstructured":"Costelloe T, Louge R, Tomimatsu N, et al. The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection. Nature. 2012;489:581\u20134.","journal-title":"Nature"},{"key":"1557_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1053\/j.seminoncol.2015.02.003","volume":"42","author":"A Covre","year":"2015","unstructured":"Covre A, Coral S, Di Giacomo AM, Taverna P, Azab M, Maio M. Epigenetics meets immune checkpoints. Semin Oncol. 2015;42:506\u201313.","journal-title":"Semin Oncol"},{"key":"1557_CR32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/jcb.200304096","volume":"162","author":"M Cremer","year":"2003","unstructured":"Cremer M, K\u00fcpper K, Wagler B, et al. Inheritance of gene density\u2013related higher order chromatin arrangements in normal and tumor cell nuclei. J Cell Biol. 2003;162:809\u201320.","journal-title":"J Cell Biol"},{"key":"1557_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrm805","volume":"3","author":"D D\u2019Amours","year":"2002","unstructured":"D\u2019Amours D, Jackson SP. The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat Rev Mol Cell Biol. 2002;3:317\u201327.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1557_CR34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1349-7006.2010.01840.x","volume":"102","author":"KK Dhillon","year":"2011","unstructured":"Dhillon KK, Swisher EM, Taniguchi T. Secondary mutations of BRCA1\/2 and drug resistance. Cancer Sci. 2011;102:663\u20139.","journal-title":"Cancer Sci"},{"key":"1557_CR35","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1096\/fj.04-3041rev","volume":"19","author":"R Dip","year":"2005","unstructured":"Dip R, Naegeli H. More than just strand breaks: the recognition of structural DNA discontinuities by DNA-dependent protein kinase catalytic subunit. FASEB J. 2005;19:704\u201315.","journal-title":"FASEB J"},{"key":"1557_CR36","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/35050000","volume":"408","author":"JA Downs","year":"2000","unstructured":"Downs JA, Lowndes NF, Jackson SP. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature. 2000;408:1001\u20134.","journal-title":"Nature"},{"key":"1557_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.molcel.2004.12.003","volume":"16","author":"JA Downs","year":"2004","unstructured":"Downs JA, Allard S, Jobin-Robitaille O, et al. Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol Cell. 2004;16:979\u201390.","journal-title":"Mol Cell"},{"key":"1557_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002974","volume":"8","author":"M Durand-Dubief","year":"2012","unstructured":"Durand-Dubief M, Will WR, Petrini E, et al. SWI\/SNF-like chromatin remodeling factor Fun30 supports point centromere function in S. cerevisiae. PLoS Genet. 2012;8:e1002974.","journal-title":"PLoS Genet"},{"key":"1557_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1515\/BC.2005.087","volume":"386","author":"A Eberharter","year":"2005","unstructured":"Eberharter A, Ferreira R, Becker P. Dynamic chromatin: concerted nucleosome remodelling and acetylation. Biol Chem. 2005;386:745\u201351.","journal-title":"Biol Chem"},{"key":"1557_CR40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s12253-015-9905-z","volume":"21","author":"N Emami","year":"2015","unstructured":"Emami N, Saadat I, Omidvari S. Susceptibility to colorectal cancer and two genetic polymorphisms of XRCC4. Pathol Oncol Res. 2015;21:881\u20135.","journal-title":"Pathol Oncol Res"},{"key":"1557_CR41","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.80.3.820","volume":"80","author":"J Erikson","year":"1983","unstructured":"Erikson J, Ar-Rushdi A, Drwinga HL, Nowell PC, Croce CM. Transcriptional activation of the translocated c-myc oncogene in Burkitt lymphoma. Proc Natl Acad Sci. 1983;80:820\u20134.","journal-title":"Proc Natl Acad Sci"},{"key":"1557_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500723","volume":"1","author":"O Fedorov","year":"2015","unstructured":"Fedorov O, Castex J, Tallant C, et al. Selective targeting of the BRG\/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance. Sci Adv. 2015;1:e1500723.","journal-title":"Sci Adv"},{"key":"1557_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0026-895X(24)26393-8","volume":"56","author":"P Frit","year":"1999","unstructured":"Frit P, Canitrot Y, Muller C, et al. Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen. Mol Pharmacol. 1999;56:141\u20136.","journal-title":"Mol Pharmacol"},{"key":"1557_CR44","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/ajt.12834","volume":"14","author":"D Gardner","year":"2014","unstructured":"Gardner D, Jeffery LE, Sansom DM. Understanding the CD28\/CTLA-4 (CD152) pathway and its implications for costimulatory blockade. Am J Transplant. 2014;14:1985\u201391.","journal-title":"Am J Transplant"},{"key":"1557_CR45","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1600-0854.2007.00638.x","volume":"8","author":"G Gerlitz","year":"2007","unstructured":"Gerlitz G, Livnat I, Ziv C, Yarden O, Bustin M, Reiner O. Migration cues induce chromatin alterations. Traffic. 2007;8:1521\u20139.","journal-title":"Traffic"},{"key":"1557_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101848","volume":"9","author":"C Giallongo","year":"2014","unstructured":"Giallongo C, Parrinello N, Tibullo D, et al. Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients. PLoS ONE. 2014;9:e101848.","journal-title":"PLoS ONE"},{"key":"1557_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29245817","volume":"29","author":"MS Gilardini Montani","year":"2024","unstructured":"Gilardini Montani MS, Benedetti R, Cirone M. Targeting EZH2 in cancer: mechanisms, pathways, and therapeutic potential. Molecules. 2024;29:5817.","journal-title":"Molecules"},{"key":"1557_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-014-0006-2","volume":"9","author":"R Gonz\u00e1lez-Barrios","year":"2014","unstructured":"Gonz\u00e1lez-Barrios R, Soto-Reyes E, Quiroz-Baez R, et al. Differential distribution of HP1 proteins after trichostatin a treatment influences chromosomal stability in HCT116 and WI-38 cells. Cell Div. 2014;9:6.","journal-title":"Cell Div"},{"key":"1557_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/embo-reports\/kvf005","volume":"3","author":"CM Green","year":"2002","unstructured":"Green CM, Almouzni G. When repair meets chromatin. First in series on chromatin dynamics. EMBO Rep. 2002;3:28\u201333.","journal-title":"EMBO Rep"},{"key":"1557_CR50","doi-asserted-by":"crossref","unstructured":"Grigoletto A, Lestienne P, Rosenbaum J. The multifaceted proteins Reptin and Pontin as major players in cancer. Biochimica Et Biophysica Acta (BBA) - Reviews on Cancer. 2011;1815:147\u201357.","DOI":"10.1016\/j.bbcan.2010.11.002"},{"key":"1557_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.256214.114","volume":"29","author":"S Guillemette","year":"2015","unstructured":"Guillemette S, Serra RW, Peng M, Hayes JA, Konstantinopoulos PA, Green MR, et al. Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4. Genes Dev. 2015;29:489\u201394.","journal-title":"Genes Dev"},{"key":"1557_CR52","doi-asserted-by":"crossref","unstructured":"Hagelkruys A, Sawicka A, Rennmayr M and Seiser C: The Biology of HDAC in Cancer: The Nuclear and Epigenetic Components. 2011; p 13\u201337.","DOI":"10.1007\/978-3-642-21631-2_2"},{"key":"1557_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1557_CR54","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1158\/1535-7163.MCT-06-0636","volume":"6","author":"JAF Hannay","year":"2007","unstructured":"Hannay JAF, Liu J, Zhu Q-S, et al. RAD51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53\/activator protein 2 transcriptional regulation. Mol Cancer Ther. 2007;6:1650\u201360.","journal-title":"Mol Cancer Ther"},{"key":"1557_CR55","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ijc.11106","volume":"105","author":"LT Hansen","year":"2003","unstructured":"Hansen LT, Lundin C, Spang-Thomsen M, Petersen LN, Helleday T. The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer. Int J Cancer. 2003;105:472\u20139.","journal-title":"Int J Cancer"},{"key":"1557_CR56","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/carcin\/bgq064","volume":"31","author":"T Helleday","year":"2010","unstructured":"Helleday T. Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis. 2010;31:955\u201360.","journal-title":"Carcinogenesis"},{"key":"1557_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06640-5","volume":"7","author":"Z Hou","year":"2024","unstructured":"Hou Z, Yu T, Yi Q, et al. High-complexity of DNA double-strand breaks is key for alternative end-joining choice. Commun Biol. 2024;7:936.","journal-title":"Commun Biol"},{"key":"1557_CR58","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature13194","volume":"508","author":"KVM Huber","year":"2014","unstructured":"Huber KVM, Salah E, Radic B, et al. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Nature. 2014;508:222\u20137.","journal-title":"Nature"},{"key":"1557_CR59","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nature07215","volume":"455","author":"P Huertas","year":"2008","unstructured":"Huertas P, Cort\u00e9s-Ledesma F, Sartori AA, Aguilera A, Jackson SP. CDK targets Sae2 to control DNA-end resection and homologous recombination. Nature. 2008;455:689\u201392.","journal-title":"Nature"},{"key":"1557_CR60","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41388-019-1127-5","volume":"39","author":"M Janiszewska","year":"2020","unstructured":"Janiszewska M. The microcosmos of intratumor heterogeneity: the space-time of cancer evolution. Oncogene. 2020;39:2031\u20139.","journal-title":"Oncogene"},{"key":"1557_CR61","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1093\/nar\/gkp1222","volume":"38","author":"R Janke","year":"2010","unstructured":"Janke R, Herzberg K, Rolfsmeier M, et al. A truncated DNA-damage-signaling response is activated after DSB formation in the G1 phase of Saccharomyces cerevisiae. Nucleic Acids Res. 2010;38:2302\u201313.","journal-title":"Nucleic Acids Res"},{"key":"1557_CR62","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD. Translating the Histone Code. Science. 2001;293:1074\u201380.","journal-title":"Science"},{"key":"1557_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1139\/o05-115","volume":"83","author":"CN Johnson","year":"2005","unstructured":"Johnson CN, Adkins NL, Georgel P. Chromatin remodeling complexes: ATP-dependent machines in action. Biochem Cell Biol. 2005;83:405\u201317.","journal-title":"Biochem Cell Biol"},{"key":"1557_CR64","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45:592\u2013601.","journal-title":"Nat Genet"},{"key":"1557_CR65","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrc1691","volume":"5","author":"WG Kaelin","year":"2005","unstructured":"Kaelin WG. The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer. 2005;5:689\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1557_CR66","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.15252\/embr.201642352","volume":"17","author":"V Kari","year":"2016","unstructured":"Kari V, Mansour WY, Raul SK, et al. Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness. EMBO Rep. 2016;17:1609\u201323.","journal-title":"EMBO Rep"},{"key":"1557_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature04384","volume":"439","author":"M-C Keogh","year":"2006","unstructured":"Keogh M-C, Kim J-A, Downey M, et al. A phosphatase complex that dephosphorylates \u03b3H2AX regulates DNA damage checkpoint recovery. Nature. 2006;439:497\u2013501.","journal-title":"Nature"},{"key":"1557_CR68","doi-asserted-by":"publisher","first-page":"11774","DOI":"10.1073\/pnas.1410626111","volume":"111","author":"K Kim","year":"2014","unstructured":"Kim K, Skora AD, Li Z, et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. Proc Natl Acad Sci U S A. 2014;111:11774\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1557_CR69","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)00081-7","volume":"102","author":"JE Krebs","year":"2000","unstructured":"Krebs JE, Fry CJ, Samuels ML, Peterson CL. Global role for chromatin remodeling enzymes in mitotic gene expression. Cell. 2000;102:587\u201398.","journal-title":"Cell"},{"key":"1557_CR70","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12551-020-00663-y","volume":"12","author":"A Kumar","year":"2020","unstructured":"Kumar A, Kono H. Heterochromatin protein 1 (HP1): interactions with itself and chromatin components. Biophys Rev. 2020;12:387\u2013400.","journal-title":"Biophys Rev"},{"key":"1557_CR71","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1126\/science.1103455","volume":"306","author":"T Kusch","year":"2004","unstructured":"Kusch T, Florens L, Macdonald WH, et al. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science. 2004;306:2084\u20137.","journal-title":"Science"},{"key":"1557_CR72","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1158\/1535-7163.MCT-14-0372","volume":"14","author":"S-J Kwon","year":"2015","unstructured":"Kwon S-J, Lee S-K, Na J, et al. Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo. Mol Cancer Ther. 2015;14:597\u2013607.","journal-title":"Mol Cancer Ther"},{"key":"1557_CR73","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.molcel.2010.12.003","volume":"40","author":"L Lan","year":"2010","unstructured":"Lan L, Ui A, Nakajima S, et al. The ACF1 complex is required for DNA double-strand break repair in human cells. Mol Cell. 2010;40:976\u201387.","journal-title":"Mol Cell"},{"key":"1557_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13287-020-01611-z","volume":"11","author":"A Lange-Consiglio","year":"2020","unstructured":"Lange-Consiglio A, Romele P, Magatti M, et al. Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells. Stem Cell Res Ther. 2020;11:99.","journal-title":"Stem Cell Res Ther"},{"key":"1557_CR75","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(00)81482-8","volume":"94","author":"SE Lee","year":"1998","unstructured":"Lee SE, Moore JK, Holmes A, Umezu K, Kolodner RD, Haber JE. Saccharomyces Ku70, Mre11\/Rad50, and RPA proteins regulate adaptation to G2\/M arrest after DNA damage. Cell. 1998;94:399\u2013409.","journal-title":"Cell"},{"key":"1557_CR76","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/emboj.2010.27","volume":"29","author":"H-S Lee","year":"2010","unstructured":"Lee H-S, Park J-H, Kim S-J, Kwon S-J, Kwon J. A cooperative activation loop among SWI\/SNF, \u03b3-H2AX and H3 acetylation for DNA double-strand break repair. EMBO J. 2010;29:1434\u201345.","journal-title":"EMBO J"},{"key":"1557_CR77","doi-asserted-by":"crossref","unstructured":"Lee S, Kim J, Jeong E and Myung K. DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategies. DNA Repair (Amst). 2025;153:103887.","DOI":"10.1016\/j.dnarep.2025.103887"},{"key":"1557_CR78","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.molcel.2007.11.001","volume":"28","author":"BM Lengsfeld","year":"2007","unstructured":"Lengsfeld BM, Rattray AJ, Bhaskara V, Ghirlando R, Paull TT. Sae2 is an endonuclease that processes hairpin DNA cooperatively with the Mre11\/Rad50\/Xrs2 complex. Mol Cell. 2007;28:638\u201351.","journal-title":"Mol Cell"},{"key":"1557_CR79","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/jnci\/djn123","volume":"100","author":"X Li","year":"2008","unstructured":"Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. JNCI J Natl Cancer Inst. 2008;100:672\u20139.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1557_CR80","doi-asserted-by":"publisher","first-page":"10044","DOI":"10.1074\/jbc.M109.079095","volume":"285","author":"D-Q Li","year":"2010","unstructured":"Li D-Q, Pakala SB, Reddy SDN, et al. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 -proliferating cell nuclear antigen pathway. J Biol Chem. 2010;285:10044\u201352.","journal-title":"J Biol Chem"},{"key":"1557_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2023.11.012","volume":"14","author":"N Li","year":"2024","unstructured":"Li N, Lun D, Gong N, et al. Targeting the chromatin structural changes of antitumor immunity. J Pharm Anal. 2024;14:100905.","journal-title":"J Pharm Anal"},{"key":"1557_CR82","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, Kang K, Chen P, et al. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024;23:108.","journal-title":"Mol Cancer"},{"key":"1557_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106887","volume":"88","author":"X Liu","year":"2020","unstructured":"Liu X, Wang J. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma. Int Immunopharmacol. 2020;88:106887.","journal-title":"Int Immunopharmacol"},{"key":"1557_CR84","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1038\/onc.2011.554","volume":"31","author":"W Liu","year":"2012","unstructured":"Liu W, Lindberg J, Sui G, et al. Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene. 2012;31:3939\u201348.","journal-title":"Oncogene"},{"key":"1557_CR85","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.1128\/MCB.24.21.9682-9694.2004","volume":"24","author":"B Llorente","year":"2004","unstructured":"Llorente B, Symington LS. The Mre11 nuclease is not required for 5\u2032 to 3\u2032 resection at multiple HO-induced double-strand breaks. Mol Cell Biol. 2004;24:9682\u201394.","journal-title":"Mol Cell Biol"},{"key":"1557_CR86","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0092-8674(02)00614-1","volume":"108","author":"KS Lobachev","year":"2002","unstructured":"Lobachev KS, Gordenin DA, Resnick MA. The Mre11 complex is required for repair of hairpin-capped double-strand breaks and prevention of chromosome rearrangements. Cell. 2002;108:183\u201393.","journal-title":"Cell"},{"key":"1557_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.70023","volume":"4","author":"N Lu","year":"2025","unstructured":"Lu N, Rong G, Han W. Epi-immunotherapy in cancer treatment: mechanisms, clinical progress, and future directions. Cancer Innov. 2025;4:e70023.","journal-title":"Cancer Innov"},{"key":"1557_CR88","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/38444","volume":"389","author":"K Luger","year":"1997","unstructured":"Luger K, M\u00e4der AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 \u00c5 resolution. Nature. 1997;389:251\u201360.","journal-title":"Nature"},{"key":"1557_CR89","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cell.2010.10.019","volume":"143","author":"E Luk","year":"2010","unstructured":"Luk E, Ranjan A, FitzGerald PC, Mizuguchi G, Huang Y, Wei D, et al. Stepwise histone replacement by SWR1 requires dual activation with histone H2A.Z and canonical nucleosome. Cell. 2010;143:725\u201336.","journal-title":"Cell"},{"key":"1557_CR90","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s43018-024-00777-2","volume":"5","author":"NW Mabe","year":"2024","unstructured":"Mabe NW, Perry JA, Malone CF, Stegmaier K. Pharmacological targeting of the cancer epigenome. Nat Rev Cancer. 2024;5:844\u201365.","journal-title":"Nat Rev Cancer"},{"key":"1557_CR91","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1093\/nar\/gkf496","volume":"30","author":"JP Madigan","year":"2002","unstructured":"Madigan JP. DNA double-strand break-induced phosphorylation of Drosophila histone variant H2Av helps prevent radiation-induced apoptosis. Nucleic Acids Res. 2002;30:3698\u2013705.","journal-title":"Nucleic Acids Res"},{"key":"1557_CR92","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1073\/pnas.101617298","volume":"98","author":"F Magdinier","year":"2001","unstructured":"Magdinier F, Wolffe AP. Selective association of the methyl-CpG binding protein MBD2 with the silent p14\/p16 locus in human neoplasia. Proc Natl Acad Sci U S A. 2001;98:4990\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1557_CR93","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/carcin\/bgp042","volume":"30","author":"S Majid","year":"2009","unstructured":"Majid S, Dar AA, Ahmad AE, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009;30:662\u201370.","journal-title":"Carcinogenesis"},{"key":"1557_CR94","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41573-024-00978-5","volume":"23","author":"HA Malone","year":"2024","unstructured":"Malone HA, Roberts CWM. Chromatin remodellers as therapeutic targets. Nat Rev Drug Discov. 2024;23:661\u201381.","journal-title":"Nat Rev Drug Discov"},{"key":"1557_CR95","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12929-022-00856-5","volume":"29","author":"J Mandal","year":"2022","unstructured":"Mandal J, Mandal P, Wang T-L, Shih I-M. Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response. J Biomed Sci. 2022;29:71.","journal-title":"J Biomed Sci"},{"key":"1557_CR96","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2567.2007.02689.x","volume":"123","author":"J Manning","year":"2008","unstructured":"Manning J, Indrova M, Lubyova B, et al. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours. Immunology. 2008;123:218\u201327.","journal-title":"Immunology"},{"key":"1557_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262311271","volume":"26","author":"L Marcut","year":"2025","unstructured":"Marcut L, Brata RD, Barb AC, et al. Targeting DNA damage response and immune crosstalk in cancer: mechanistic insights and therapeutic opportunities. Int J Mol Sci. 2025;26:11271.","journal-title":"Int J Mol Sci"},{"key":"1557_CR98","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/138920208784533610","volume":"9","author":"A Masi","year":"2008","unstructured":"Masi A, Antoccia A. NBS1 heterozygosity and cancer risk. Curr Genomics. 2008;9:275\u201381.","journal-title":"Curr Genomics"},{"key":"1557_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091408","volume":"17","author":"V Mc Neil","year":"2025","unstructured":"Mc Neil V, Lee SW. Advancing cancer treatment: a review of immune checkpoint inhibitors and combination strategies. Cancers (Basel). 2025;17:1408.","journal-title":"Cancers (Basel)"},{"key":"1557_CR100","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature07312","volume":"455","author":"EP Mimitou","year":"2008","unstructured":"Mimitou EP, Symington LS. Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing. Nature. 2008;455:770\u20134.","journal-title":"Nature"},{"key":"1557_CR101","doi-asserted-by":"crossref","unstructured":"Morandell S and Yaffe MB. Exploiting Synthetic Lethal Interactions Between DNA Damage Signaling, Checkpoint Control, and p53 for Targeted Cancer Therapy. 2012. p 289\u2013314.","DOI":"10.1016\/B978-0-12-387665-2.00011-0"},{"key":"1557_CR102","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/genetics\/159.4.1423","volume":"159","author":"S Moreau","year":"2001","unstructured":"Moreau S, Morgan EA, Symington LS. Overlapping functions of the Saccharomyces cerevisiae Mre11, Exo1 and Rad27 nucleases in DNA metabolism. Genetics. 2001;159:1423\u201333.","journal-title":"Genetics"},{"key":"1557_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012143","volume":"5","author":"M Morillo-Huesca","year":"2010","unstructured":"Morillo-Huesca M, Clemente-Ruiz M, And\u00fajar E, Prado F. The SWR1 histone replacement complex causes genetic instability and genome-wide transcription misregulation in the absence of H2A.Z. PLoS ONE. 2010;5:e12143.","journal-title":"PLoS ONE"},{"key":"1557_CR104","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1038\/emboj.2008.171","volume":"27","author":"I Morin","year":"2008","unstructured":"Morin I, Ngo H-P, Greenall A, Zubko MK, Morrice N, Lydall D. Checkpoint-dependent phosphorylation of Exo1 modulates the DNA damage response. EMBO J. 2008;27:2400\u201310.","journal-title":"EMBO J"},{"key":"1557_CR105","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.leu.2404285","volume":"20","author":"M Mosor","year":"2006","unstructured":"Mosor M, Zi\u00f3\u0142kowska I, Pernak-Schwarz M, Januszkiewicz-Lewandowska D, Nowak J. Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia. 2006;20:1454\u20136.","journal-title":"Leukemia"},{"key":"1557_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102287","volume":"100","author":"J Mullen","year":"2021","unstructured":"Mullen J, Kato S, Sicklick JK, Kurzrock R. Targeting ARID1A mutations in cancer. Cancer Treat Rev. 2021;100:102287.","journal-title":"Cancer Treat Rev"},{"key":"1557_CR107","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/ncb1343","volume":"8","author":"R Murr","year":"2006","unstructured":"Murr R, Loizou JI, Yang Y-G, Cuenin C, Li H, Wang Z-Q, et al. Histone acetylation by Trrap\u2013Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat Cell Biol. 2006;8:91\u20139.","journal-title":"Nat Cell Biol"},{"key":"1557_CR108","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1038\/sj.onc.1210605","volume":"26","author":"R Murr","year":"2007","unstructured":"Murr R, Vaissi\u00e8re T, Sawan C, Shukla V, Herceg Z. Orchestration of chromatin-based processes: mind the TRRAP. Oncogene. 2007;26:5358\u201372.","journal-title":"Oncogene"},{"key":"1557_CR109","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-020-2296-7","volume":"583","author":"R Nasrallah","year":"2020","unstructured":"Nasrallah R, Imianowski CJ, Bossini-Castillo L, et al. A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells. Nature. 2020;583:447\u201352.","journal-title":"Nature"},{"key":"1557_CR110","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6501","volume":"7","author":"S Niyomnaitham","year":"2019","unstructured":"Niyomnaitham S, Parinyanitikul N, Roothumnong E, et al. Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene. PeerJ. 2019;7:e6501.","journal-title":"PeerJ"},{"key":"1557_CR111","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.semcdb.2022.03.011","volume":"135","author":"P Oberdoerffer","year":"2023","unstructured":"Oberdoerffer P, Miller KM. Histone H2A variants: diversifying chromatin to ensure genome integrity. Semin Cell Dev Biol. 2023;135:59\u201372.","journal-title":"Semin Cell Dev Biol"},{"key":"1557_CR112","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/onc.2010.592","volume":"30","author":"H Ogiwara","year":"2011","unstructured":"Ogiwara H, Ui A, Otsuka A, et al. Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI\/SNF chromatin remodeling and the recruitment of non-homologous end joining factors. Oncogene. 2011;30:2135\u201346.","journal-title":"Oncogene"},{"key":"1557_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-associated macrophages in tumor immunity. Front Immunol. 2020;11:583084.","journal-title":"Front Immunol"},{"key":"1557_CR114","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1101\/gad.1440206","volume":"20","author":"M Papamichos-Chronakis","year":"2006","unstructured":"Papamichos-Chronakis M, Krebs JE, Peterson CL. Interplay between Ino80 and Swr1 chromatin remodeling enzymes regulates cell cycle checkpoint adaptationin response to DNA damage. Genes Dev. 2006;20:2437\u201349.","journal-title":"Genes Dev"},{"key":"1557_CR115","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252\u201364.","journal-title":"Nat Rev Cancer"},{"key":"1557_CR116","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1038\/sj.emboj.7601291","volume":"25","author":"J-H Park","year":"2006","unstructured":"Park J-H, Park E-J, Lee H-S, Kim SJ, Hur S-K, Imbalzano AN, et al. Mammalian SWI\/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. EMBO J. 2006;25:3986\u201397.","journal-title":"EMBO J"},{"key":"1557_CR117","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.str.2011.09.010","volume":"19","author":"YB Park","year":"2011","unstructured":"Park YB, Chae J, Kim YC, Cho Y. Crystal structure of human Mre11: understanding tumorigenic mutations. Structure. 2011;19:1591\u2013602.","journal-title":"Structure"},{"key":"1557_CR118","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1002\/ijc.27822","volume":"132","author":"R Paw\u0142owski","year":"2013","unstructured":"Paw\u0142owski R, M\u00fchl SM, Sulser T, Krek W, Moch H, Schraml P. Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer. 2013;132:E11-17.","journal-title":"Int J Cancer"},{"key":"1557_CR119","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/ncb1895","volume":"11","author":"G Peng","year":"2009","unstructured":"Peng G, Yim E-K, Dai H, et al. BRIT1\/MCPH1 links chromatin remodelling to DNA damage response. Nat Cell Biol. 2009;11:865\u201372.","journal-title":"Nat Cell Biol"},{"key":"1557_CR120","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature15520","volume":"527","author":"D Peng","year":"2015","unstructured":"Peng D, Kryczek I, Nagarsheth N, et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 2015;527:249\u201353.","journal-title":"Nature"},{"key":"1557_CR121","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","volume":"12","author":"N Petrucelli","year":"2010","unstructured":"Petrucelli N, Daly MB, Feldman GL. Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet Med. 2010;12:245\u201359.","journal-title":"Genet Med"},{"key":"1557_CR122","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature08629","volume":"463","author":"ED Pleasance","year":"2010","unstructured":"Pleasance ED, Stephens PJ, O\u2019Meara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 2010;463:184\u201390.","journal-title":"Nature"},{"key":"1557_CR123","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.dnarep.2009.04.011","volume":"8","author":"SN Powell","year":"2009","unstructured":"Powell SN, Bindra RS. Targeting the DNA damage response for cancer therapy. DNA Repair (Amst). 2009;8:1153\u201365.","journal-title":"DNA Repair (Amst)"},{"key":"1557_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25074092","volume":"25","author":"SS Prime","year":"2024","unstructured":"Prime SS, Darski P, Hunter KD, Cirillo N, Parkinson EK. A review of the repair of DNA double strand breaks in the development of oral cancer. Int J Mol Sci. 2024;25:4092.","journal-title":"Int J Mol Sci"},{"key":"1557_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116461","volume":"44","author":"J Qian","year":"2025","unstructured":"Qian J, Watanabe T, Watanabe R, et al. BET family BRD3 initiates DSB-induced chromatin remodeling with TIP60 to promote R-loop-mediated HR. Cell Rep. 2025;44:116461.","journal-title":"Cell Rep"},{"key":"1557_CR126","first-page":"560","volume":"63","author":"DN Reisman","year":"2003","unstructured":"Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res. 2003;63:560\u20136.","journal-title":"Cancer Res"},{"key":"1557_CR127","doi-asserted-by":"crossref","unstructured":"Rosa M, Von Harder M, Aiese Cigliano R, Schl\u00f6gelhofer P, Mittelsten Scheid O. The Arabidopsis SWR1 chromatin-remodeling complex is important for DNA repair, somatic recombination, and meiosis. Plant Cell. 2013;25:1990\u20132001.","DOI":"10.1105\/tpc.112.104067"},{"key":"1557_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/srep22828","volume":"6","author":"SD Rutledge","year":"2016","unstructured":"Rutledge SD, Douglas TA, Nicholson JM, et al. Selective advantage of trisomic human cells cultured in non-standard conditions. Sci Rep. 2016;6:22828.","journal-title":"Sci Rep"},{"key":"1557_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100998","volume":"57","author":"A Salminen","year":"2020","unstructured":"Salminen A. Activation of immunosuppressive network in the aging process. Ageing Res Rev. 2020;57:100998.","journal-title":"Ageing Res Rev"},{"key":"1557_CR130","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.biochem.77.061306.125255","volume":"77","author":"J San Filippo","year":"2008","unstructured":"San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008;77:229\u201357.","journal-title":"Annu Rev Biochem"},{"key":"1557_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s13072-025-00603-8","volume":"18","author":"MV Santopietro","year":"2025","unstructured":"Santopietro MV, Ferreri D, Prozzillo Y, Dimitri P, Messina G. The multitalented TIP60 chromatin remodeling complex: wearing many hats in epigenetic regulation, cell division and diseases. Epigenetics Chromatin. 2025;18:40.","journal-title":"Epigenetics Chromatin"},{"key":"1557_CR132","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.biocel.2006.03.003","volume":"38","author":"V Sapountzi","year":"2006","unstructured":"Sapountzi V, Logan IR, Robson CN. Cellular functions of TIP60. Int J Biochem Cell Biol. 2006;38:1496\u2013509.","journal-title":"Int J Biochem Cell Biol"},{"key":"1557_CR133","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.molcel.2021.03.032","volume":"81","author":"R Schep","year":"2021","unstructured":"Schep R, Brinkman EK, Leemans C, et al. Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance. Mol Cell. 2021;81:2216-2230.e10.","journal-title":"Mol Cell"},{"key":"1557_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020466","volume":"15","author":"P Sehgal","year":"2023","unstructured":"Sehgal P, Chaturvedi P. Chromatin and cancer: implications of disrupted chromatin organization in tumorigenesis and its diversification. Cancers (Basel). 2023;15:466.","journal-title":"Cancers (Basel)"},{"key":"1557_CR135","doi-asserted-by":"publisher","unstructured":"Shen M, Jiang X, Peng Q, Oyang L, Ren Z, Wang J, Peng M, Zhou Y, Deng X, Liao Q. ThecGAS-STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications. J Hematol Oncol . 2025 Apr 5;18(1):40. https:\/\/doi.org\/10.1186\/s13045-025-01691-5.","DOI":"10.1186\/s13045-025-01691-5"},{"key":"1557_CR136","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/35020123","volume":"406","author":"X Shen","year":"2000","unstructured":"Shen X, Mizuguchi G, Hamiche A, Wu C. A chromatin remodelling complex involved in transcription and DNA processing. Nature. 2000;406:541\u20134.","journal-title":"Nature"},{"key":"1557_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62593-9","volume":"10","author":"M Silasi","year":"2020","unstructured":"Silasi M, You Y, Simpson S, et al. Human chorionic gonadotropin modulates CXCL10 expression through histone methylation in human decidua. Sci Rep. 2020;10:5785.","journal-title":"Sci Rep"},{"key":"1557_CR138","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2009.07.013","volume":"138","author":"M Sinha","year":"2009","unstructured":"Sinha M, Watanabe S, Johnson A, Moazed D, Peterson CL. Recombinational repair within heterochromatin requires ATP-dependent chromatin remodeling. Cell. 2009;138:1109\u201321.","journal-title":"Cell"},{"key":"1557_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9070081","volume":"9","author":"B Sishc","year":"2017","unstructured":"Sishc B, Davis A. The role of the core non-homologous end joining factors in carcinogenesis and cancer. Cancers (Basel). 2017;9:81.","journal-title":"Cancers (Basel)"},{"key":"1557_CR140","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.1073\/pnas.121009898","volume":"98","author":"JA Solinger","year":"2001","unstructured":"Solinger JA, Heyer W-D. Rad54 protein stimulates the postsynaptic phase of Rad51 protein-mediated DNA strand exchange. Proc Natl Acad Sci. 2001;98:8447\u201353.","journal-title":"Proc Natl Acad Sci"},{"key":"1557_CR141","doi-asserted-by":"crossref","unstructured":"Solinger JA, Lutz G, Sugiyama T, Kowalczykowski SC, Heyer W-D. Rad54 protein stimulates heteroduplex DNA formation in the synaptic phase of DNA strand exchange via specific interactions with the presynaptic Rad51 nucleoprotein filament. J Mol Biol. 2001;307:1207\u201321 (11Edited by M. Belfort).","DOI":"10.1006\/jmbi.2001.4555"},{"key":"1557_CR142","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/14737140.2016.1211936","volume":"16","author":"P Specenier","year":"2016","unstructured":"Specenier P. Ipilimumab in melanoma. Expert Rev Anticancer Ther. 2016;16:811\u201326.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1557_CR143","first-page":"31","volume":"750","author":"FKT Stanley","year":"2013","unstructured":"Stanley FKT, Moore S, Goodarzi AA. CHD chromatin remodelling enzymes and the DNA damage response. Mutat Res - Fundam Mol Mech Mutagen. 2013;750:31\u201344.","journal-title":"Mutat Res - Fundam Mol Mech Mutagen"},{"key":"1557_CR144","doi-asserted-by":"publisher","first-page":"E10981","DOI":"10.1073\/pnas.1712514114","volume":"114","author":"ML Stone","year":"2017","unstructured":"Stone ML, Chiappinelli KB, Li H, et al. Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden. Proc Natl Acad Sci U S A. 2017;114:E10981\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1557_CR145","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63972","volume":"10","author":"AR Strom","year":"2021","unstructured":"Strom AR, Biggs RJ, Banigan EJ, et al. HP1\u03b1 is a chromatin crosslinker that controls nuclear and mitotic chromosome mechanics. Elife. 2021;10:e63972.","journal-title":"Elife"},{"key":"1557_CR146","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.str.2014.10.017","volume":"23","author":"C Tallant","year":"2015","unstructured":"Tallant C, Valentini E, Fedorov O, et al. Molecular basis of histone tail recognition by human TIP5 PHD finger and bromodomain of the chromatin remodeling complex NoRC. Structure. 2015;23:80\u201392.","journal-title":"Structure"},{"key":"1557_CR147","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.dnarep.2004.05.015","volume":"3","author":"PT Tran","year":"2004","unstructured":"Tran PT, Erdeniz N, Symington LS, Liskay RM. EXO1-A multi-tasking eukaryotic nuclease. DNA Repair (Amst). 2004;3:1549\u201359.","journal-title":"DNA Repair (Amst)"},{"key":"1557_CR148","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature04148","volume":"438","author":"T Tsukuda","year":"2005","unstructured":"Tsukuda T, Fleming AB, Nickoloff JA, Osley MA. Chromatin remodelling at a DNA double-strand break site in Saccharomyces cerevisiae. Nature. 2005;438:379\u201383.","journal-title":"Nature"},{"key":"1557_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang C-H, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10:227.","journal-title":"Signal Transduct Target Ther"},{"key":"1557_CR150","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cell.2004.11.033","volume":"119","author":"H van Attikum","year":"2004","unstructured":"van Attikum H, Fritsch O, Hohn B, Gasser SM. Recruitment of the INO80 complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA double-strand break repair. Cell. 2004;119:777\u201388.","journal-title":"Cell"},{"key":"1557_CR151","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1038\/sj.emboj.7601835","volume":"26","author":"H van Attikum","year":"2007","unstructured":"van Attikum H, Fritsch O, Gasser SM. Distinct roles for SWR1 and INO80 chromatin remodeling complexes at chromosomal double-strand breaks. EMBO J. 2007;26:4113\u201325.","journal-title":"EMBO J"},{"key":"1557_CR152","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.gde.2006.02.006","volume":"16","author":"PD Varga-Weisz","year":"2006","unstructured":"Varga-Weisz PD, Becker PB. Regulation of higher-order chromatin structures by nucleosome-remodelling factors. Curr Opin Genet Dev. 2006;16:151\u20136.","journal-title":"Curr Opin Genet Dev"},{"key":"1557_CR153","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","volume":"58","author":"J Waibl Polania","year":"2025","unstructured":"Waibl Polania J, Hoyt-Miggelbrink A, Tomaszewski WH, et al. Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity. 2025;58:232-246.e6.","journal-title":"Immunity"},{"key":"1557_CR154","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1568009623666230522115229","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Z, Wu J, Yan H, Wang Y, He J. The mutation and low expression of ARID1A are predictive of a poor prognosis and high immune infiltration in triple-negative breast cancer. Curr Cancer Drug Targets. 2024;24:59\u201368.","journal-title":"Curr Cancer Drug Targets"},{"key":"1557_CR155","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-13-3608","volume":"74","author":"R Watanabe","year":"2014","unstructured":"Watanabe R, Ui A, Kanno S, Ogiwara H, Nagase T, Kohno T, et al. SWI\/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability. Cancer Res. 2014;74:2465\u201375.","journal-title":"Cancer Res"},{"key":"1557_CR156","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.1073096","volume":"297","author":"IB Weinstein","year":"2002","unstructured":"Weinstein IB. Addiction to oncogenes--the Achilles heal of cancer. Science. 2002;297:63\u20134.","journal-title":"Science"},{"key":"1557_CR157","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1128\/MCB.18.9.5392","volume":"18","author":"K Weiss","year":"1998","unstructured":"Weiss K, Simpson RT. High-resolution structural analysis of chromatin at specific loci: Saccharomyces cerevisiae silent mating type locus HML \u03b1. Mol Cell Biol. 1998;18:5392\u2013403.","journal-title":"Mol Cell Biol"},{"key":"1557_CR158","doi-asserted-by":"publisher","first-page":"10855","DOI":"10.1074\/jbc.M414388200","volume":"280","author":"B Wolner","year":"2005","unstructured":"Wolner B, Peterson CL. ATP-dependent and ATP-independent roles for the Rad54 chromatin remodeling enzyme during recombinational repair of a DNA double strand break. J Biol Chem. 2005;280:10855\u201360.","journal-title":"J Biol Chem"},{"key":"1557_CR159","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-15-0077-T","volume":"3","author":"DM Woods","year":"2015","unstructured":"Woods DM, Sodr\u00e9 AL, Villagra A, Sarnaik A, Sotomayor EM, Weber J. HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade. Cancer Immunol Res. 2015;3:1375\u201385.","journal-title":"Cancer Immunol Res"},{"key":"1557_CR160","doi-asserted-by":"crossref","unstructured":"Wu Q, Sharma S, Cui H, et al. Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells. Oncotarget. 2016a;7:27158\u201375.","DOI":"10.18632\/oncotarget.8384"},{"key":"1557_CR161","doi-asserted-by":"crossref","unstructured":"Wu Q, Madany P, Dobson JR, et al. The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation. Oncotarget. 2016b;7:38270\u201381.","DOI":"10.18632\/oncotarget.9505"},{"key":"1557_CR162","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-019-1763-5","volume":"575","author":"S Wu","year":"2019","unstructured":"Wu S, Turner KM, Nguyen N, et al. Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature. 2019;575:699\u2013703.","journal-title":"Nature"},{"key":"1557_CR163","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.stem.2009.11.002","volume":"6","author":"H Wurdak","year":"2010","unstructured":"Wurdak H, Zhu S, Romero A, et al. An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell. 2010;6:37\u201347.","journal-title":"Cell Stem Cell"},{"key":"1557_CR164","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-387665-2.00010-9","volume":"110","author":"Y Xu","year":"2012","unstructured":"Xu Y, Xu C, Price BD. Mechanistic links between ATM and histone methylation codes during DNA repair. Prog Mol Biol Transl Sci. 2012;110:263\u201388.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1557_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051619","volume":"15","author":"Y Xu","year":"2023","unstructured":"Xu Y, Nowsheen S, Deng M. DNA repair deficiency regulates immunity response in cancers: molecular mechanism and approaches for combining immunotherapy. Cancers (Basel). 2023;15:1619.","journal-title":"Cancers (Basel)"},{"key":"1557_CR166","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1158\/0008-5472.CAN-18-3259","volume":"79","author":"M Yamamoto","year":"2019","unstructured":"Yamamoto M, Jin C, Hata T, et al. MUC1-C integrates chromatin remodeling and PARP1 activity in the DNA damage response of triple-negative breast cancer cells. Cancer Res. 2019;79:2031\u201341.","journal-title":"Cancer Res"},{"key":"1557_CR167","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1158\/1541-7786.MCR-09-0119","volume":"7","author":"Y Ye","year":"2009","unstructured":"Ye Y, Xiao Y, Wang W, et al. Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death. Mol Cancer Res. 2009;7:1984\u201399.","journal-title":"Mol Cancer Res"},{"key":"1557_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/biology14111556","volume":"14","author":"A Yeasmin","year":"2025","unstructured":"Yeasmin A, Torrente MP. Histone post-translational modifications and DNA double-strand break repair in neurodegenerative diseases: an epigenetic perspective. Biology. 2025;14:1556.","journal-title":"Biology"},{"key":"1557_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05165-8","volume":"24","author":"Y Yu","year":"2023","unstructured":"Yu Y, Sun Y, Li Z, Li J, Tian D. Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer. BMC Bioinformatics. 2023;24:44.","journal-title":"BMC Bioinformatics"},{"key":"1557_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108451","volume":"103","author":"F Yuan","year":"2022","unstructured":"Yuan F, Cong Z, Cai X, et al. BACH1 as a potential target for immunotherapy in glioblastomas. Int Immunopharmacol. 2022;103:108451.","journal-title":"Int Immunopharmacol"},{"key":"1557_CR171","doi-asserted-by":"publisher","first-page":"57452","DOI":"10.18632\/oncotarget.10767","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang C, Wang S, Liu Y, Yang C. Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancer. Oncotarget. 2016;7:57452\u201363.","journal-title":"Oncotarget"},{"key":"1557_CR172","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/cam4.2012","volume":"8","author":"L Zhang","year":"2019","unstructured":"Zhang L, Huang Y, Feng Z, et al. Comparison of breast cancer risk factors among molecular subtypes: a case-only study. Cancer Med. 2019;8:1882\u201392.","journal-title":"Cancer Med"},{"key":"1557_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04785-x","volume":"13","author":"Y-L Zhang","year":"2022","unstructured":"Zhang Y-L, Deng L, Liao L, et al. Chromatin complexes subunit BAP18 promotes triple-negative breast cancer progression through transcriptional activation of oncogene S100A9. Cell Death Dis. 2022;13:408.","journal-title":"Cell Death Dis"},{"key":"1557_CR174","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13148-025-01856-6","volume":"17","author":"H Zhang","year":"2025","unstructured":"Zhang H, Pang Y, Yi L, Wang X, Wei P, Wang H, et al. Epigenetic regulators combined with tumour immunotherapy: current status and perspectives. Clin Epigenetics. 2025;17:51.","journal-title":"Clin Epigenetics"},{"key":"1557_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217587","volume":"616","author":"H Zheng","year":"2025","unstructured":"Zheng H, Hua Y, Yang S, et al. Epigenetic modification and tumor immunity: unraveling the interplay with the tumor microenvironment and its therapeutic vulnerability and implications. Cancer Lett. 2025;616:217587.","journal-title":"Cancer Lett"},{"key":"1557_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107205","volume":"204","author":"L Zhou","year":"2024","unstructured":"Zhou L, Yu C-W. Epigenetic modulations in triple-negative breast cancer: therapeutic implications for tumor microenvironment. Pharmacol Res. 2024;204:107205.","journal-title":"Pharmacol Res"},{"key":"1557_CR177","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1093\/nar\/gky128","volume":"46","author":"J Zhou","year":"2018","unstructured":"Zhou J, Li J, Serafim RB, et al. Human CHD1 is required for early DNA-damage signaling and is uniquely regulated by its N terminus. Nucleic Acids Res. 2018;46:3891\u2013905.","journal-title":"Nucleic Acids Res"},{"key":"1557_CR178","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1158\/1078-0432.CCR-19-1351","volume":"26","author":"L Zhou","year":"2020","unstructured":"Zhou L, Mudianto T, Ma X, Riley R, Uppaluri R. Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti\u2013PD-1 resistance in head and neck cancer. Clin Cancer Res. 2020;26:290\u2013300.","journal-title":"Clin Cancer Res"},{"key":"1557_CR179","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117988119","volume":"119","author":"C Zhou","year":"2022","unstructured":"Zhou C, Wang D, Li J, et al. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2. Proc Natl Acad Sci U S A. 2022;119:e2117988119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1557_CR180","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cell.2008.08.037","volume":"134","author":"Z Zhu","year":"2008","unstructured":"Zhu Z, Chung W-H, Shim EY, Lee SE, Ira G. Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends. Cell. 2008;134:981\u201394.","journal-title":"Cell"},{"key":"1557_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-113","volume":"12","author":"I Zi\u00f3\u0142kowska-Suchanek","year":"2013","unstructured":"Zi\u00f3\u0142kowska-Suchanek I, Mosor M, Wierzbicka M, Rydzanicz M, Baranowska M, Nowak J. The MRN protein complex genes: MRE11 and RAD50 and susceptibility to head and neck cancers. Mol Cancer. 2013;12:113.","journal-title":"Mol Cancer"},{"key":"1557_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16152677","volume":"16","author":"N Zohourian","year":"2024","unstructured":"Zohourian N, Coll E, Dever M, Sheahan A, Burns-Lane P, Brown JAL. Evaluating the cellular roles of the lysine acetyltransferase Tip60 in cancer: a multi-action molecular target for precision oncology. Cancers (Basel). 2024;16:2677.","journal-title":"Cancers (Basel)"},{"key":"1557_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040713","volume":"13","author":"V Zolota","year":"2021","unstructured":"Zolota V, Tzelepi V, Piperigkou Z, Kourea H, Papakonstantinou E, Argentou M-I, et al. Epigenetic alterations in triple-negative breast cancer\u2014the critical role of extracellular matrix. Cancers (Basel). 2021;13:713.","journal-title":"Cancers (Basel)"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01557-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:03:09Z","timestamp":1791810189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01557-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1557"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01557-7","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"182"}}